Suppr超能文献

用于细胞微囊化的聚合材料。

Polymeric Materials for Cell Microencapsulation.

作者信息

Aijaz A, Perera D, Olabisi Ronke M

机构信息

Department of Biomedical Engineering, Rutgers University, 599 Taylor Road, Piscataway, NJ, 08854, USA.

出版信息

Methods Mol Biol. 2017;1479:79-93. doi: 10.1007/978-1-4939-6364-5_6.

Abstract

Mammalian cells have been microencapsulated within both natural and synthetic polymers for over half a century. Specifically, in the last 36 years microencapsulated cells have been used therapeutically to deliver a wide range of drugs, cytokines, growth factors, and hormones while enjoying the immunoisolation provided by the encapsulating material. In addition to preventing immune attack, microencapsulation prevents migration of entrapped cells. Cells can be microencapsulated in a variety of geometries, the most common being solid microspheres and hollow microcapsules. The micrometer scale permits delivery by injection and is within diffusion limits that allow the cells to provide the necessary factors that are missing at a target site, while also permitting the exchange of nutrients and waste products. The majority of cell microencapsulation is performed with alginate/poly-L-lysine microspheres. Since alginate itself can be immunogenic, for cell-based therapy applications various groups are investigating synthetic polymers to microencapsulate cells. We describe a protocol for the formation of microspheres and microcapsules using the synthetic polymer poly(ethylene glycol) diacrylate (PEGDA).

摘要

半个多世纪以来,哺乳动物细胞一直被微囊化在天然和合成聚合物中。具体而言,在过去36年里,微囊化细胞已被用于治疗,以递送多种药物、细胞因子、生长因子和激素,同时享受封装材料提供的免疫隔离。除了防止免疫攻击外,微囊化还能防止被包裹细胞的迁移。细胞可以被微囊化为多种几何形状,最常见的是固体微球和中空微胶囊。微米尺度允许通过注射进行递送,并且在扩散限制范围内,这使得细胞能够提供靶位点缺失的必要因子,同时还允许营养物质和代谢产物的交换。大多数细胞微囊化是用藻酸盐/聚-L-赖氨酸微球进行的。由于藻酸盐本身可能具有免疫原性,对于基于细胞的治疗应用,各个研究小组正在研究用于微囊化细胞的合成聚合物。我们描述了一种使用合成聚合物聚(乙二醇)二丙烯酸酯(PEGDA)形成微球和微胶囊的方案。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验